PEPTIDES DERIVED FROM THE ONCOGENE PROTEINE BCR-ABL EXPRESSED BY LEUKEMIC CELLS AND UTILISATION THEREOF FOR THE THERAPY OF HUMAN LEUKEMIAE
摘要
The invention relates to peptides capable of inducing a response of human cytotoxic T lymphocytes (CTL) specifically directed against cells expressing the fusion protein BCR-ABL.
申请公布号
WO9718232(A2)
申请公布日期
1997.05.22
申请号
WO1996FR01799
申请日期
1996.11.14
申请人
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE M;INSTITUT PASTEUR;LANGLADE-DEMOYEN, PIERRE;ABASTADO, JEAN-PIERRE;KOURILSKY, PHILIPPE
发明人
LANGLADE-DEMOYEN, PIERRE;ABASTADO, JEAN-PIERRE;KOURILSKY, PHILIPPE